Clay Capital

Clay Capital appears to be closely associated with, or an earlier designation for, New Protein Capital, a Singapore-based venture capital firm. New Protein Capital is a specialist investor focused on transformative solutions addressing critical bottlenecks within the global food and feed system. Their investment thesis centers on fostering innovation in areas such as alternative proteins, cultivated meat, sustainable aquaculture, and other disruptive food technologies, primarily across the Asia-Pacific region. The firm aims to support companies that can enhance food security, improve sustainability, and create more efficient food supply chains.

The firm actively seeks out early-stage companies, typically investing in Seed to Series A rounds. They are known for their strategic support beyond just capital, leveraging their deep industry expertise and network within the food tech ecosystem. New Protein Capital launched a dedicated fund in 2021, aiming to deploy $25 million into promising startups. This fund underscores their commitment to building a robust portfolio of companies poised to reshape the future of food.

Regarding their investment strategy, New Protein Capital typically writes initial checks ranging from $500,000 to $2 million. This range allows them to be a significant early partner for startups, providing crucial capital for product development, market entry, and scaling operations. Their portfolio includes notable companies like Next Gen Foods (makers of TiNDLE plant-based chicken), TurtleTree (cultivated milk), and CellX (cultivated meat), demonstrating their commitment to pioneering technologies in the alternative protein space. Their strategic investments are designed to accelerate the adoption of sustainable and innovative food solutions, contributing to a more resilient and environmentally friendly global food system.